# AGNG holdings: all 84 positions

> All 84 AGNG holdings with weights, as of May 31, 2026. The top 3 are NOVOB 3.79%, LLY 3.58% and Edwards Lifesciences Corporation 3.37%. Free CSV download.

Data as of May 31, 2026. Rebuilt every trading night.

AGNG held 84 positions as of May 31, 2026. Novo Nordisk A/S is the largest at 3.79%; the top 10 are 32.1% of the fund.

Source: Form N-PORT filed with the SEC (https://www.sec.gov/Archives/edgar/data/1432353/000204825126006452/primary_doc.xml).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Novo Nordisk A/S | NOVOB | 3.79% |
| 2 | Eli Lilly & Co | LLY | 3.58% |
| 3 | Edwards Lifesciences Corporation |  | 3.37% |
| 4 | Roche Holding AG |  | 3.21% |
| 5 | AbbVie Inc | ABBV | 3.16% |
| 6 | Welltower Inc | WELL | 3.07% |
| 7 | Ventas Inc | VTR | 3.06% |
| 8 | Merck & Co Inc | MRK | 2.99% |
| 9 | Bristol-Myers Squibb Co | BMY | 2.98% |
| 10 | Amgen Inc. |  | 2.93% |
| 11 | Johnson & Johnson | JNJ | 2.88% |
| 12 | UCB SA |  | 2.86% |
| 13 | AstraZeneca PLC | AZN | 2.80% |
| 14 | Stryker Corp | SYK | 2.79% |
| 15 | Chugai Pharmaceutical Co., Ltd. |  | 2.78% |
| 16 | Sandoz Group AG |  | 2.62% |
| 17 | Medtronic PLC | MDT | 2.60% |
| 18 | Regeneron Pharmaceuticals Inc | REGN | 2.48% |
| 19 | Boston Scientific Corp | BSX | 2.44% |
| 20 | Alcon AG |  | 2.35% |
| 21 | BeOne Medicines AG | ONC | 2.24% |
| 22 | Celltrion, Inc. |  | 2.10% |
| 23 | Dexcom Inc | DXCM | 2.01% |
| 24 | Astellas Pharma Inc. |  | 1.83% |
| 25 | United Therapeutics Corp | UTHR | 1.73% |
| | Cash and other net assets | | 0.27% |

The largest 25 of 84 positions are shown. All of them: https://etfiq.com/funds/agng/holdings/agng-holdings.csv (CSV) or https://etfiq.com/data/books/agng.json (JSON).

Fund page: https://etfiq.com/funds/agng

Cite: ETFIQ, Holdings of AGNG, data as of May 31, 2026. https://etfiq.com/funds/agng/holdings/